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Class II molecules are critical in normal immune responses. In association with
antigen, class 11 molecules are recognized by TCRs . This recognition leads to the
activation of those T cells and ultimately a response to that antigen . It is also clear
that these class II molecules are important in the development of disease both in
the human and mouse (1) . For example, in the human system, the DQf3 chain (the
human homologue ofmouse I-A) has been implicated in the development of insulin-
dependent diabetes mellitus (IDDM)' (1, 2) . Indeed, it has been suggested that a
single amino acid change at position 57 in the DQf6 chain can alter the predisposi-
tion to IDDM . In addition, the DR/3 chain has been implicated in the development
ofrheumatoid arthritis (1, 3) and the DP(O chain has been implicated in celiac dis-
ease (4) .
Similarly, in the murine system, the response to certain well-defined antigens is
mediated by I-A or I-E . In the nonobese diabetic (NOD) mouse, the animal model
for IDDM, a gene linked to the H-2 complex has been shown to contribute to the
development ofIDDM (5) . The I-A(3 chain from theNOD mouse has been studied
and contains a unique sequence involving amino acids 57-58 (6) . It has been sug-
gested that this unique sequence may contribute to disease susceptibility, possibly
by allowing the presentation of self antigens . Finally, it has recently been suggested
that genes linked to the H-2 complex may contribute to the development of lupus
in mice (7) . This H-2 linkage appears to be the case for genes contributed by the
NZW mouse (8) to the development of accelerated autoimmunity in (NZB x
NZW)F, mice (7), as well as genes contributed bySWR in (NZB x SWR)F, mice
(9) .
The observations that nephritis in the (NZB x SWR)Fi mouse is linked to the
I-Aqs locus of the SWR mouse and that antibodies to murine class II molecules
have been used to ameliorate disease in (NZB x NZW)F, mice (10) suggest that
the H-2-linked genes oftheNZW that accelerate autoimmunity are the class II genes
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A UNIQUE SEQUENCE OF THE NZW I-E,O CHAIN
themselves. We therefore evaluated these genes for a unique sequence that might
contribute to autoimmunity. Because the majority of the polymorphism of class II
genes lies in the second exons encoding the first domains, we sequenced the second
exons of I-Act, I-A#, I-Ea, and I-Eg of NZW using the technique of the polymerase
chain reaction (11). We report here that the second exons of NZW I-A a and 0 and
I-Ea are identical to their counterparts of the previously sequenced u haplotype,
and that the second exon of NZW I-Ef3 is identical to the second exon of I-E°O ex-
cept for single C-G base change at nucleotide position 215 resulting in an arginine
for threonine substitution at amino acid position 72. The substituted G and argi-




Oligonucleotides corresponding to previously sequenced mouse class II
I-Aa, I-AFB, I-Ea, and I-Ef3 genes were constructed usingthe ABI DNA synthesizer (Applied
Biosystems, Inc., Foster City, CA) (Table I). The primer oligonucleotides corresponded to
the first 18-24 and the last 21-24 bases of the second exon of the I-A genes, the first 19 and
the last 21 bases of the second exon of I-Ea, the first 17 and the last 21 bases of the second
exon of the I-E0 gene, and the most 3' 21 bases of the first intron and the most 5' 21 bases
of the second intron of the I-E0 gene. The screening oligonucleotides for I-Aa and R and
I-Ea corresponded to an 18-24 base nonpolymorphic region found in the second exon of
these genes.
Polymerase Chain Reaction (PCR).
￿
For I-Ace and 0, and for I-E0 and PCR was performed
essentially as described in the procedure from the Perkin Elmer Cetus Gene Amp DNA
Amplification Reagent kit (see also reference 12) (Perkin Elmer Cetus, Norwalk, CT). Briefly,
1 p,g of NZW genomic DNA was amplified in a solution of reaction buffer (50 mM KCI,
10 mM Tris-Cl, pH 8.3, 1.5 MM MgC12, 0.01% gelatin), 0.20 mM of each dNTP, 1.0 J,M
each of 5' primer and 3' primer, and Taq polymerase (2.5 U) in a total volume of 100 pl.
The mixture was overlaid with mineral oil and taken through 30 cycles of amplification (1.5
min at 94°C, 2 min at 50-55°C [42 °C for intronic primers], 3 min at 72 °C) . The entire
reaction was ligated into Sma I-digested M13mpI8, and Escherichia coli strainJM109was trans-
formed (13) with the ligation mixture. After transformation, plaques were transferred to
Nitroplus 2000 (Micron Separations Inc., Westboro, MA) and screened using a third oligo-
nucleotide made to a nonpolymorphic portion ofthe second exon of the class II gene (Table
I). The probe was end-labeled with 1'-[32P]dATP (14). Filters were prehybridized in 6 x SSC
(1 x SSC: 0.15 M NaCl, 0.015 M sodium citrate, pH 7 .0) (15), 5 x Denhardt's solution (1 x
Denhardt's: 0.02% Ficoll, 0.02% polyvinylpyrrolidone, 0.02% BSA), 0.05% sodium pyro-
phosphate, 100 pg/ml salmon sperm DNA, 0.5 % SDS, and hybridized in 6 x SSC, 1 x Den-
hardt's, 100 pg/ml yeast tRNA, 0.05% sodium pyrophosphate, and 5 x 106 cpm of each
probe per filter at 37°C overnight (16). The filters were washed at 37°C in 6x SSC, 0.05%
sodium pyrophosphate and subjected to autoradiography. Positive plaques were picked and
sequenced.
For I-Ea, single-stranded template for sequencingwas prepared directly from PCR using
a modification of the limiting primer technique (12, 14). Molar primer ratios of 1 :15 or 1 :20
were used in a PCR reaction solution of 200 or 400 11, using the same constituent concentra-
tions as with the I-Aa and 0, and I-E0 PCRs. The limiting primer was set at a concentration
of 10 ng/0.1 ml reaction mixture, and the PCR was run for 40 cycles, with denaturation at
94°C for 2 min, annealing at 55°C for 3 min, and extenstion at 72 °C for 2 min. Reaction
mixtures that showed the major product band to be the expected size on a 3% agarose gel
were selected for sequencing.
DNA Sequencing.
￿
Positive plaques were sequenced by the Sanger dideoxy chain termina-
tion method (17) using [35S]dATP and the Sequenase DNA Sequencing Kit (U.S. Biochem-
ical Corp., Cleveland, OH). The sequencing reactions were run on 6% denaturingpolyacryl-
amide gels, dried, and subjected to autoradiography Sequence was performed on DNA iso-SCHIFFENBAUER ET AL.
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lated from at least three independent PCRs for each gene to preclude any sequence errors
introduced during the PCR.
Southern Analysis.
￿
An aliquot of the PCR was electrophoresed on a 3 % Nusieve agarose
gel (FMC Bio Products, Rockland, ME) and transferred by the method of Southern (18)
to Genescreen plus (New England Nuclear, Boston, MA). Preparation of the probe and hy-




ThePCR wasperformedon NZWgenomicDNA usingoligonucle-
otides corresponding to I-A° a and a chain genes (Table I). The amplified DNA
from each PCR was ligated into M13. Plaques were screened with a third oligonu-
cleotide correspondingto anonpolymorphic portion oftheclass II genelocatedwithin
the amplified DNA (Table 1). Positive plaques were picked and the PCR insert was
sequenced. The sequences obtained for the second exons of both NZW I-Act and
I-A/3were identical tothose ofthe previously sequencedu haplotype withnonucleo-
tide or amino acid changes. Comparisons between NZW and previously sequenced
I-Act genes and polypeptides are shown in Fig. 1. The isoleucine at position 46 ap-
pears to be unique to the I-A°a protein (Fig. 1 B), and represents a conservative
substitution for the valine found in most haplotypes.
NZW I-A,8.
￿
The DNA and protein sequence for the first domain of I-A13 are
shown in Fig. 2. Theleucine at position 8 and the tyrosine at position 81 are unique
to the I-A°/3 protein and are not found in any other known sequences. The leu-
cine at position8 representsaconservative change from valine present in most other
haplotypes. Thetyrosine at 81 is anonconservative change from the histidine found
in most other haplotypes. Of interest, the glutamine at position 85 and valine at
position 88 seen in I-A°o and NZW I-A0 are also both found in the NOD I-A(3
molecule (6) and are therefore unique to the u and NOD haplotypes.
NZWI-Ea.
￿
TheDNA andproteinsequencesofI-Ea second exons ofNZW and
haplotypes u,k, and d are shown in Fig. 3. The I-Ea second exons of NZW and
u are identical, butdiffer from theother knownhaplotypes bytwochanges, as previ-
ously reported (19). The tyrosine for phenylalanine substitution at position 22 is




PCR was performed on NZW genomic DNA using oligonucleo-
tides corresponding to known I-E/3 sequences ofseveral haplotypes (Table I). Be-
cause of initial difficulties in isolating amplified DNA corresponding to the NZW
I-E(3 second exon, an additional methodological step was introduced to ensure that
the NZW I-E/3 second exon was actually being amplified. A portion ofeach PCR
waselectrophoresed through anagarosegel and blotted onto nitrocellulose; the filter
was hybridized with a third oligonucleotide corresponding to the nonpolymorphic
nucleotides 40-60 ofI-ES (Table I). B10.BR genomic DNA (k haplotype) andoligo-
nucleotides to the k haplotype were used as a positive control. A band at -270 by
corresponding to amplfied I-E(3 from the k haplotype was seen. Also present, but
to alesser extent, was amplifiedDNA corresponding toNZW I-E(3 (datanotshown).
With thisassurance, the amplified DNA from thelatter PCR was ligated into M13.
Plaques were again screenedwith the nonpolymorphic I-EBB oligonucleotide 40-60,
positive plaques were picked, and the PCR insert was sequencedwith the nonpoly-974
￿
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NZW Asp Lye Lys Slu Thr Ile TIP Met Lou Pro Glu Phe Ala Sin Lou Arg Ser Phe Asp Pro
u
￿
. . . . . . . .. . . . . . . .. . . . . .. . . . . . .. . .. . .. . . . . . . . . . . . . .. . .. . . . . . . .
k
￿
. . . . . . . .. . . . . .. Val . . . . . . . . . . . . . . . . .. . . . . . . .. . . . . Arg . . Glu . .
d
￿
. . . . . . . . . Lys . . . Val . . . Arg . . . . . . . . . . .. Sly . . . . . . Ile Lou .. . Glu . .
b
￿
. . . . .. . .. . .. . .. Val . . . .. . .. . .. . .. . . .. Sl y . . . . . . Ala . . . . . . . . .. .
I
￿
. . . . . . .. . . . . .. . Val . . . Arg .. . . . . . . . . . Sly .. . . . . Thr . .. . . . . .. . ..
q
￿




NZW Sin Sly Sly Lou Sin Asn Ile Ale Thr Sly Lys His Asn Lou Sty Val Lou Thr Lys Arg
u
￿
. .. . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . .. . .. . . . . ..
k
￿
. . . . . . . .. . . . . .. . .. . . . . . . . . . . . . . . . . .. . . . . . . Slu Ile .. . .. . . . . .. .
d
￿
. . . . . . . . . . . . . . . . .. . . . . . . Ala Glu .. . . .. . .. . . . . .. Ile . . . .. . . . . .. .
b
￿
. . . . . . . .. . . . . .. . .. . . . .. . Val Val .. . . .. . . . . . . . . . . . . . . . . . . . . . .. .
I
￿
. . . . . . . . . . . . .. . Glu . . . . . . . .. . . . . . . . . . .. . .. . . . . Ile . .. . . . . . .. .
88
Ser Asn Ser Thr Pro Ala Thr Asn
FIGURE 1 .
￿
Nucleotide and predicted protein sequences ofI-Aa. Dashed lines indicate identity
with theNZW sequence . TheNZW and u sequences are identical. (A)Nucleotide sequences of
the second exon ofI-Act from NZWandu (26) . The oligonucleotides used in the PCRare under-
lined . The sequences arenumbered from the first nucleotide ofthe second exon. (B) Predicted
protein sequences for the first domains of I-Act from NZW and haplotypes u, k, d, b, f, and
q (26-29). The sequences are numbered from the first amino acid of the mature protein . The
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Val Sly Ser Tyr Sly Ile Val Val Tyr Sln Ser
20
Pro
. .. . ..
Slu Asp Asp Ile Glu . . . . ..
. . .
. . .
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.. . .. . . . . . . . .. . . . . . .. . .. . . . . .. Phe .. . .. . Thr Thr . . . . .. . . . . .. . . .
. . . .. . . . . .. . .. . . . . . . . . . . . . . . . . Thr . . . . . . . . . Ser . . . . . . . . . . . . . . .
. .. . .. . . . . . . . . . . . . . . . . . . .. . .. . Phe . . . . .. . . . $er . . . . . .
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k
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s
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NOD
￿





.. .. .. . . .. .. . . .. . . . . . . . . . . . .. .. .. .. . .. .. .. . . . .. .. . . . .. .. .. . .. ..
Q
￿
---------------C------------0_GT----AC..A---_.___ ._ . ._ ..__ . . ._ .
k
￿




C------------0_,r----AC..A_ ._ .__ ..______. . .__ .__
f
￿
---------------C------------ ,T,T----AC_ .__.__ .__ .. .____ ._ . ._.__
NOD
￿
-------C-------C.. . . . . . . .. .. . . . .. .. .. . . . .. .. .. .. . .. .. . . . . . .. .. .
FIGURE 2.
￿
See facing page for B and figure legend.
morphic I-EO oligonucleotide 40-60, positive plaques were picked, and the PCR
insert wassequenced. Fig. 4shows acomparison between I-E)3nucleotide and amino
acid sequences, respectively, from various haplotypes. The sequence of the second
exon of the NZW I-EO gene corresponds to the previously sequenced u haplotype
except forasingle nucleotide change (C-G) at base 215. This change wasconfirmed
by sequencing 12 independentclones isolated from five independentPCRs representing
both orientations. Two of these clones were isolated from PCRs in which only in-
tronic oligonucleotides flanking the second exon were used as primers. This change
results in a nonconservative amino acid substitution at position 72 where a threo-
nine is replaced by an arginine. Of note, both the substituted G and arginine are
also present in the I-E$/3 gene and polypeptide, respectively, at the corresponding
positions.
Discussion
In this studywe demonstratethat within thelimits ofthe PCR andchoice ofprimers,
the sequences of the second exons of NZW I-Act, I-A(3, and I-Ece are all identical
to those of the previously sequenced u haplotype, while the second exon of NZW
I-Ea is identical to that of the u haplotype except for a change at amino acid 72.
Because thePCR amplifiesthe oligonucleotides used as primers forthe amplification
of the second exon, it is possible that a single base change present in the region of
the second exon annealing to the primer couldbe missed. Forthis reason we cannot
exclude a single base difference (potentially resulting in an amino acid difference)
between u and NZW in these regions of I-Atx, I-Ag, and I-Em However, the useN21V
￿
His Phi Lou Val Oln Phi Gin Pro Phi Cys Tyr Phi Thr Aso Sly
u
￿
Sly Asp Set Big At- . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
NZW Thr Sin Art lie Art Tyr Val Thr Art Tyr lie Tyr Ain Art Glu Glu Tyr Lou Arp Phi
9
￿
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d
￿




NZW Tyr Asn Lys Sin "' Tyr "' Lou Olu Art Thr Art Ali Glu Lou Asp Thr Val Cys Art
u
￿
... .. . . .. ... . . .. . . . . . .. .. . . .. .. . ... . .. .. . . . . . .. .. . . . . ...
q
￿
Trp . . . Set . . . Pro Glu Ile . . . . . . . . . . . . . . . . . . . . . Val . . . . . . . . . . . . . . .
k
￿
Trp . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
a
￿
. . . ... .. . . .. . .. . . .. . . .. Sin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
f
￿
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
d
￿
Trp . . . Sar . . . Pro Glu lie . . . . . . . . . . . . . . . . . . . . . Val . . . . . . Ala . . . . . .
b
￿
Trp . . . Sir . . . Pro Slu Ile . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
NOD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Ale . . . . . .
to
NZW Tyr Ain Tyr Glu Glu Tar Glu Val Pro Thr Ser Lou Art Art Lou Glu
u
￿
. .. .. . .. . . .. ... . . . ... .. . . .. .. . . .. ... .. . . .. ... .. .
FIGURE 2.
￿
Nucleotide and predicted protein sequencesof I-AS. Dashed linesindicate identity
with theNZW sequence. Asterisksindicate gaps relative to the qhaplotype sequence. TheNZW
and u sequences are identical (A) Nucleotide sequences of the firstdomain of I-AS chains from
NZW, and haplotypes u, q, k, s, fand NOD (27, 28, 30-34). The oligonucleotides used in the
PCR are underlined. The sequences are numbered from thefirst base present in the coding re-
gion of the uhaplotype. The beginning of the second exon is indicated by the vertical bar. (B)
Predicted protein sequences of the first domains of I-A0 chains from NZW and haplotypes u,
q, k, s, f, d, b, and NOD (27, 28, 30-34). The sequences are numbered from the first amino
acid of the mature protein.
ofoligonucleotides correspondingto the intronic sequencesflanking thesecond exon
of NZW I-Efl confirm that the sequences of I-E°o and NZW I-EBB second exons are
identical except for the single base change.
Previouswork hasdemonstrated thatthecontribution ofNZW toaccelerated au-
toimmunity in the (NZB x NZW)FL mouse is linked to the H-2 complex (7). Our
q His . . . . . . . . . Sly Val . . . Thr His . . . . . . . . . . . . . . . . . . . . .
k His . . . . . . . . . L ys . . . . . . Thr . . . . . . . . . . . . . . . . . . . . . . . .
s Hit . . . . . . . . . Sly Val . . . Thr HIS . . . . . . . . . . . . . . . . . . . . .
f His . . . . . . . . . Sly Val . . . Thr . . . . . . . . . . . . . . . . . . . . . . . .
d His . . . . . . . . . Sly Pro . . . Thr Sir . . . . . . . . . . . . . . . . . . . . .
b HI, . . . . . . . . . 01y Pro . . . Thr His . . . . . . . . . . . . . . . . . . . . .
NOD His . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
q . . . Asn . . . . . . . . . . . . . . . Vol All . . . Lou Lys Sly 019 . . . . . . . . . . . . . . . . . .
k . . . Asn . . . . . . . . . . . . . . . Val His . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
a . . . . .. ... . . . ... .. . . .. Vol Phi . . . . . . Lys Sly Big . . . . . . . . . . . . . . . . . .
t ... Asn . . . . . . . . . . . . . . . Val Phi . . . . . . Lys Sly Slu . . . . . . . . . . . . . . . . . .
d . . . Ain . . . . . . . . . . . . . . . Vol . . . . . . . . . Lys Sly Glu . . . . . . Tyr . . . . . . . . .
b . . . . . . . . . . . . . . . . . . . . . Val Tyr . . . . . . lust Sly Glu . . . . . . . . . . . . . . . . . .
HM . . . . . . . . . . . . . . . . . . . . . Val His . . . . . . Lys Oly Olu . . . . . . . . . . . . . . . . . .
30 40978
￿
























I Is Lys Glu Glu His Thr Ile Ile Gin Ala tilu Phe Tyr Lou Lou Pro Asp Lys Arg t;ly Glu Tyr kbt Phe
u
￿








N2W Asp Phe Asp Gly Asp Glu Ile Phe His Val Asp Ile Glu Lys Ser Glu Thr Ile Trip Arg Lou Glu tilu Phe
u
￿








NZII Ala Lys phe Ala Ser Phe Glu Ala Gin Gly Ala Leu Ale Asn ile Ala Val Asp Lys Ala Asn Lou Asp Val
u
￿












Nucleotide and predictedprotein sequences of I-Etx. Dashed lines indicate identity
with the NZWsequence. TheNZWandu sequences are identical (19). (A)Nucleotide sequences
of the second exons of I-Ea from NZW and u (19). The oligonucleotides used in thePCR are
underlined. Thesequencesarenumbered from thefirstnucleotide ofthesecond exon.(B)Predicted
protein sequencesforthe first domains of I-Ea from NZW andhaplotypes u, d, and k(19). The
sequences are numbered from the first amino acid of the mature protein.
finding of a unique sequence in the NZW class II I-Ef3 chain may offer a possible
explanation for this finding. In a related model, the (NZB x SWR)Fj mouse, it
has been shown that the contribution ofthe SWR strain (q haplotype) to the devel-
opment of nephritis is linked to the I-Ag locus (as well as the TCR (3 chain gene)
(9). Furthermore, results demonstrating an amino acid unique to the I-A/3 chain
in the NOD (6) mouse and the importance of amino acid 57 in the human DW
chain contribution to diabetes (1, 2) suggest that single amino acid changes in class
II molecules may contribute to the development ofautoimmunity. In this context,
it is possible that the arginine at position 72 that differentiates the NZW I-ES se-
quence from the I-E°(3 sequence from the I-Eua sequence may contribute to the
accelerated autoimmunity seen in the (NZB x NZW)F1 . This hypothesis is sup-
ported by the postulated class II three-dimensional structure (20) that places this
arginine on the a-helix, where is may influence.interaction with antigen or TCR.
In addition, five amino acids encoded by the second exon are unique to the NZW
(u) I-E0 chain (i.e., not present in any other known haplotypes). Many ofthe amino
acids unique to the NZW I-E0 chain are located at positions, which based on the
hypothetical model ofthe three-dimensional structure of a class II molecule (20),
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b C-T--------AACC--_.______. . . .. . .__________T_ ._ .__ .________ ._. . . .______. .C. . .. .___ ... . . . . ._ . . . . . .. . ..







k T------------A--_ .____A__ .. . ..._ .GTG.____ .______ ._________TC_. .__C___ . ._----C___ ._ ._. . .
b T____________A_ ._ ._. . .A__ .______ .GTG.. . .. . ._. ._. . . .. . .. . . . . ._____ ._.. ._.____ . . . ._ .___ . .






Pro Arg Phe Lou Gly Tyr Ser Thr Ser Glu Cys His Phe Tyr Asn Gly Thr Gin Arg Val
u
￿
Arg Gly Asp Ser Arg . .. .. . . . . . . . . . . . . . .. . . .. . . . . . . . . . .. . . . . . . . .. . . . . . . . . . . . . . . . .
k
￿
Ala Ser Phe .. . . . . Trp . . . . . . Glu . . . Cys Lys . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . .
b
￿
Lou Trp . . . . . . Glu . . . Cys Lys . . . .. . . .. . . . . . . . . . . . . . . . . .. . . . . . . . . .
d Val Arg . . . Thr . . . . . . . . . . . . . . . Glu . . . Val . .. . . . .. . . ._ . . . . . . . . . ._ . . . . . . . . . . His . . .
s
￿
Trp -__ _ . . Glu __ . . . . _ . . _ . . . . . . . . . . . __ . . . . . ._ ___ __ . . ._ ___ ---
50
NZW Arg Phe Lou Asp Arg Tyr Phe Tyr Ago Arg Glu Glu Trp Val Arg Phe Asp Ser Asp Val Gly Glu Tyr Arg Ala
u . . . . . . . . . .. . . . . . .. . . . . ._ . . . . . . . . . .. . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
k
￿
. . . Lou . . . Val . . . . . . . . . . . . . . . Lou . . . .. . Asn Lou . . . _ .. . . . . . . . . . _ . . . . . . ._ Phe . . . . . .
b
￿
--- Lou --- Glu --- --- --- --- Thr Trp --- --- Asn Lou --- --- --- --- --- --- --- . . . Phe --- ---
d
￿
--- --- -_- Glu . . . Phe lie --- ___ . . . ___ _. . Asn Lou --- --- ___ __ . . ._ ___ _ . . . . . . ._ _ . . ---
a
￿
. . . Lou .. . Giu . . . . .. . . . . . . . . . Lou . . . .. . Asn Lou . . . . .. .__ . . . . . . . . . . . . . .. Phe . . . . . .
75
NZW Vel Thr Glu Lou Gly Arg Pro Glu Ala Glu Asn Trp Asn Ser Gin Pro Glu lie Lou Glu Gln Arg Arg Ala Ala
g8
NZW Val Asp Thr Tyr Cys Arg His Asn Tyr Glu lie Ser Asp Lys Phe Lou Val Arg Arg Arg Val
u . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . .. . . . . . . . .. . . . .
k
￿
. . . . . . .. . Val . . . . . . . . . . . . . . . . . . . . . Phe . . . Asn . . . . . . ._ . Pro . . . . . . . . .
b
￿





Nucleotide and predictedprotein sequences ofI-EO. Dashed lines indicate identity
with the NZW sequence. (A) Nucleotide sequences of the first domains of the I-ES chains of
NZW and haplotypes u, k, b, and s (27, 28, 35-39). The oligonucleotides used in the PCR are
underlined. The sequencesarenumbered from thefirst base present in thecoding region of the
uhaplotype. NZW is identicalto u except fortheC-G change at nucleotide 215whichit shares
with thes haplotype (boxed). The beginning of the second exon is indicated by the vertical bar.
(B) Predictedprotein sequencesofthe firstdomains of the I-EO chains of NZW andhaplotypes
u, k, b, d, and s (27, 28, 35-39). The sequences are numbered from the first amino acid ofthe
mature protein. NZW is identicalto u except for the threonine-arginine change at amino acid
72 which it shares with the s haplotype (boxed).
A comparison oftheknownclass II sequences from the"autoimmune" haplotypes
(q, NOD, and NZW) suggests that other NZW class II molecules may also be im-
portant in contributing to autoimmunity. As mentioned in Results, the isoleucine
at position 46 in I-Act and the leucine at position 8 and tyrosine at position 81 in
I-A# are unique to the NZW (u) haplotype. According to the three-dimensional
u . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . .. . . . . . . . .. . . . Thr . . . . . . . .
k . . . . . . .. . . . . . . . . . . . . . Asp . . . . . . . . . .. . . . . . . . . . . . .. .. . Phe . . . . . . . . . Lys . . . . . . Glu
b . ._ . .. .. . . ._ . . . . . . . . . Asp . . . . . . . . . .. . . .. . . . .. . . .. . . . Phe . . . . . . . . . Lys . . . . . . Glu
d . . . _ .. . . . . . . . . . . . . . . . Asp . . . . . . . . . .. . . .. . . . .. . . . . . . . . . . . . . . . . Asp Ala . . . . . . Ser
. . . .. . . . . . . . . .. . . . Asp . . . . . . . . . .. . . . . . . . . . . . .. . . . Phe . . . . . . . . . 7_ .. . .. . .. .980
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computer model forclass II molecules (20), I-Aa isoleucine 46 falls outside the an-
tigen binding groove and would not be directly accessible to either antigen or the
TCR. However, isoleucine could cause conformational changesin otherpartsofthe
molecule. The I-AS leucine 8 is located on the 0-pleated sheet under the a-helix,
and could also potentially influence conformation. The I-AS tyrosine 81 is located
on the a-helix where it probably does not interact with antigen, but may interact
with the TCR (20).
A comparison of the NZW and q haplotypes reveals that the valine at position
15 inthe I-Aa chain is uniquely shared by both. Similarly, acomparison ofthe I-A(3
chains from NZW and NOD demonstrates that the glutamine at position 85 and
the valine at position 88 are uniquely shared by both. In addition, the I-A(3 genes
from NZW and NOD have identical nucleotide sequences in this region from bases
253-267 (Fig. 2), suggesting that a gene conversion event involving these two haplo-
typesmaybeoneexplanation forthisregion ofshared sequence. Basedonthehypothet-
ical structure of a class II molecule (20), it is unclear what role valine at position
15 in the a chain, or glutamine 85 or valine 88 in the R chain may play in antigen
presentation, as they do notappear likely to interact with antigen. However, tertiary
structural changes induced by these amino acids may be responsible for the contri-
bution of these sequences to autoimmunity.
Although the sequence of NZW I-Ea is identical at the second exon to that of
the u haplotype, this sequence still codes two unique amino acid residues relative
to other known Ea haplotypes, and may play a role in (NZB x NZW)Fi autoim-
munity. The lysine at position 75 is unique to the NZW and the u haplotypes rela-
tiveto kand d, but thesiteliesoutside the antigen binding groove ofthe constructed
computer model for the class II molecule. The unique tyrosine residue at position
22, however, is nearthe floorofthegroove to one side whereone a-helixofESjuxta-
posesagainst the Ea molecule, andcould interactwith bound antigen. Furthermore,
H-2° haplotype mice have been shown to have an Ea molecule that does not con-
sistently associate well with non-u E/3 molecules in heterozygote Fi hybrid crosses,
interfering with certain E-restricted immune responses (19). This finding could be
significant in the (NZB x NZW)F, model also, in light of the NZW identity with
the second exon of I-Eau.
While the unique sequence ofthe NZW I-Eg chain provides one explanation for
the contribution ofNZW to accelerated autoimmunity, several other explanations
exist. It is possible that there may be trans-association between individual class II
chains determined by NZB (H-2d) and NZW to form "hybrid" molecules. This hy-
pothesis is supported by results suggesting that administration of anti-I-Ad anti-
bodies to (NZB x NZW)F, mice improved their survival (10).
An additional possibility is that the NZW and H-2u class II molecules may be
immunodominant, and in this waycontribute to accelerated autoimmunity. Several
observations support this hypothesis. PL/J is u haplotype (21, 22), and is involved
in experimental allergic encephalomyelitis (EAE), the animal modelofhuman mul-
tiple sclerosis (23, 24). The NH2-terminal 37 amino acids of rat myelin basic pro-
tein(MBP) can induce EAE in PL/J mice, while theCOON-terminal 89-169 amino
acid peptide is encephalitogenic in SJL/J mice (s haplotype). However, the (PLJ x
SJL)Fj mouse develops EAE only in response to the NH2-terminal peptide ofMBP
(23, 24), suggesting that the u haplotype is immunodominant in this autoimmuneSCHIFFENBAUER ET AL.
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response. This hypothesis is supported by the observation that of 16 I-A-restricted
T cell clones recognizing MBP, only one is I-A$ restricted (23, 24). An analogous
situation may exist in (NZB x NZW)Fi lupusmice. It is possible thatthe I-A° mol-
ecule contributed by theNZW mouseisimmunodominant and maytherebypredis-
pose to self recognition.
One possible mechanism for such immunodominance derives from the concept
ofpreferential expression ofonehaplotype over another. In support ofthis concept,
it has been demonstrated that in (d x u)Fj mice there is a poor expression of I-Ed
molecules. This poor expression is apparently due to a preferential association of
E°(3 chains with the Ect chains present (25). It is possible that asimilar phenomenon
is occurring in (NZB x NZW)Fj mice.
Because both NZW and PL/J (H-2°) mice have been associated with autoimmu-
nity, it would be of interest to evaluate (NZB x PL/J)Fi mice for the presence of
alupus-like disease, and ifitis present, to compare disease severity between (NZB x
NZW)F, and (NZB x PL/J)Fl mice. To our knowledge, the (NZB x PL/J)Fl mice
have not yet been produced. Asimilar degree ofdisease severity might suggest the
uhaplotypepersewas contributingtoautoimmunity. Absenceofdisease orminimally
severe disease in the (NZB x PL/J)F, compared with the (NZB x NZW)Fi would
suggest that the substitution at position 72 in the I-E0 chain and/or NZW back-
ground genes are critical for the developmental ofaccelerated autoimmunity. How-
ever, differences in background genes between PL/J and NZW would preclude any
definitive conclusions.
It is clear that the NZW mouse is not the only strain that contributes to acceler-
ated autoimmunity, as the SWR (q) mousewhen crossedto NZB produces a similar
picture. It is therefore likely that no one class II haplotype is uniquely involved in
the development of autoimmunity, and that several, ifnot all, haplotypes may en-
code class II molecules permissive for the development ofdisease. Study of addi-
tional class II sequences should further elucidate the mechanisms by which specific
changes in sequence may predispose to disease and autoimmunity.
Summary
The (NZB x NZW)F, mouse strain develops a syndrome ofaccelerated autoim-
munity including severe renal disease and early death. Evidence suggests that class
II molecules play acentral role in this process. Previous studies have suggested that
the NZW strain contributes at least one gene to the development ofaccelerated au-
toimmunity that is linked to the H-2 complex, and antibodies to murine class II
molecules have been used to ameliorate disease in (NZB x NZW)Fi mice. We
therefore wished to sequence the class II moleculesfrom NZW mice to identify any
unique sequences that may contribute to disease development. We constructed oli-
gonucleotide primers corresponding to the 5' and 3' regions of the second exon of
class II genes from a variety ofhaplotypes, and used these primers in a polymerase
chain reaction to sequence the second exonofthe NZW I-Act, I-Ag, and I-E/3genes.
We report thatthe second exons ofNZW I-Aci, I-A(3, and I-Ea areidentical to their
counterparts ofthe previously sequenced u haplotype, and that the second exon of
NZW I-E/3 is identical to its counterpart from u except for a single base change that
results in a substitution of arginine for threonine at amino acid 72. This base and
amino acid are identical to those found at the same positions in the s haplotype.982
￿
A UNIQUE SEQUENCE OF THE NZW I-Efl CHAIN
We thank Lorraine Whiteley and Pat Parvin for expert preparation of this manuscript.
Receivedfor publication 21 December 1988 and in revisedform 30 May 1989.
References
1 . Todd, J . A., H. Acha-Orbea, J. 1 . Bell, N. Chao, Z. Fronek, C. O. Jacob, M. McDer-
mott, A. A. Sinha, L. Timmerman, L. Steinman, and H. O. McDevitt. 1988. A molec-
ular basis for MHC class II associated autoimmunity. Science (Wash. DC). 240:1003.
2 . Todd, J . A.,J. 1 . Bell, and H. O. McDevitt. 1987. HLA-DQ gene contributes to suscep-
tibility and resistance to insulin dependent diabetes mellitus. Nature (Lond.). 329:599.
3 . Gregersen, P. K., M. Shen, Q; Song, P Merryman, S. Degar, T Seki, J. Maccari, D.
Goldberg, H. Murphy, J. Schwenzer, C. Y. Wang, R. J . Winchester, G. T. Nepom, and
J. Silver. 1986. Molecular divesity of HLA-DR4 haplotypes. Proc. Nail. Acad. Sci. USA.
83 :2642.
4. M. D. Howell, J. R. Smith, R. K. Austin, D. Kelleher, G. Nepom, B. Volk, and M. F.
Kagnoff. 1988. An extended HLA-D region haplotype associated with celiac disease.
Proc. Nail. Acad. Sci. USA. 85:222.
5. Hattori, M.,J. B. Buse, R. A. Jackson, L. Glimcher, M. E. Dorf, M. Minami, S. Makino,
K. Moriwaki, H. Kuzaya, H. Imura, W. M. Strauss, J. G. Seidman, and G. S. Eisen-
barth. 1986. The NOD mouse: Recessive diabetogenic gene in the major histocompati-
bility complex. Science (Wash. DC). 231:733.
6. Acha-Orbea, H., and H. O. McDevitt. 1987. The first external domain of the non-obese
diabetic mouse class II I-A/3 chain is unique. Proc. Natl. Acad. Sci. USA. 84:2435.
7. Kotzin, B. L., and E. Palmer. 1987. The contribution ofNZW genes to lupus-like disease
in (NZB x NZW)F, mice. J. Exp. Med. 165:1237.
8 . Theofilopoulos, A. N., and F. J. Dixon. 1985. Murine models of systemic lupus
erythematosus. Adv. Immunol. 37:269.
9. Ghatak, S., K. Sainis, F. L. Owens, and S. K. Datta. 1987. T-cell receptor a and I-A/3
chain genes of normal SWR mice are linked with the development of lupus nephritis
in NZB x SWR crosses. Proc. Nail. Acad. Sci. USA. 84:6850.
10. Adelman, N. E., D. L. Watling, and H. O. McDevitt. 1983. Treatment of (NZB x
NZW)F1 disease with anti-I-A monoclonal antibodies. J Exp. Med. 158:1350.
11 . Scharf, S. J., G. T. Horn, and H. A. Erlich. 1986. Direct cloning and sequence analysis
of enzymatically amplified genomic sequences. Science (Wash. DC). 233 :1076.
12 . Gyllensten, Y., and H . A. Erlich. 1988. Generation ofsingle-stranded DNA by the poly-
merase chain reaction and its application to direct sequencing of the HLA-DQA locus.
Proc. Nail. Acad. Sci. USA. 85:7652.
13 . Hanahan, D. 1983. Studies on transformation of Escherichia coli with plasmids. J Mol.
Biol. 166:557.
14. Mihovilovic, M., andJ. E. Lee. 1989. An efficient method for sequencingPCR amplified
DNA. Biotechniques. 7 :14.
15 . Maniatis, T.; E. F Fritsch, andJ. Sambrook. 1982. Molecular Cloning. A Laboratory
Manual. Cold Spring Harbor Laboratory Publications. Cold Spring Harbor, NY. 545 pp.
16 . Duby, A., K. A.Jacobs, and A. Celeste. 1987. Using synthetic oligonucleotide as probes.
In Current Protocols in Molecular Biology. F. M. Ausubel, et al., editors. John Wiley
and Sons, New York. 6.4.1.
17 . Sanger, F, S. Nicklen, and A. R. Coulson. 1977. DNA sequencingwith chain-terminating
inhibitors. Proc. Natl. Acad. Sci. USA. 74:5463.
18 . Southern, E. M. 1975. Detection of specific sequences among DNA fragments separated
by gel electrophoresis. J. Mol. Biol. 98:503.SCHIFFENBAUER ET AL.
￿
983
19 . Ayane, M., L. Mengle-Gaw, H. O. McDevitt, C. Benoist, and D. Mathis. 1986. Ea°
and E/3° chain association: where lies the anomaly? J. Immunol. 137 :948.
20. Brown, J. H ., T Jardetzky, M. A. Saper, B. Samraoui, P. J. Bjorkman, and D. C . Wiley
1988. A hypothetical model of the foreign antigen binding site of class II histocompati-
bility molecules. Nature (Loud.). 332:845.
21 . Figueroa, E, S. Tewarson, E. Neufeld, andJ . Klein. 1982. H-2 haplotypes of strains DBR7,
B10.NZW, NFS, BQ2, STW, TOI, T02. Immunogenetics. 115:431 .
22 . Klein, J ., F. Figueroa, and C. S. David. 1983. H-2 haplotypes, genes and antigens: second
listing. Immunogenetics. 17:553 .
23 . Zamvil, S. S., P. A. Nelson, D. J. Mitchell, R. L. Knobler, R. B. Fritz, and L. Steinman.
1985. Encephalitogenic T cell clones specific for myelin basic protein.J. Exp. Med. 162:2107 .
24 . Fritz, R. B., M. J. Skeen, C. H. J. Chou, M . Garcia, and I . K. Egorov. 1985. Major
histocompatibility complex linked control ofthe murine immune response to myelin basic
protein. J Immunol. 134:2328.
25 . Conrad, P. J., and C. A. Janeway. 1984. The expression of I-E" molecules in F, hybrid
mice detected with antigen-specific, I-E`-restricted cloned T cell lines. Immunogenetics.
20:311.
26 . Benoist, C. 0., D. J. Mathis, M . R. Kanter, V. E. Williams, and H. O. McDevitt. 1983.
Regions of allelic hypervariability in the murine Act immune response gene. Cell. 34:169.
27 . Korman, A. J., J. M. Boss, T. Spris, R. Sorrentino, K. Okada, and J. L. Strominger.
1985 . Genetic complexity and expression of human class II histocompatibility antigens.
Immunol. Rev. 85:45.
28. Figueroa, F, andJ. Klein. 1986. The evolution of MHC class II genes. Immunol. Today. 7:78.
29 . Auffray, C ., A. Ben-Nun, M. Roux-Dosseto, R. N. Germain, J. G. Seidman, and J. L.
Strominger. 1983 . Polymorphism and complexity of the human DC and murine I-Au
chain genes. EMBO (Eur. Mot. Biol. Organ.) J 2:121.
30. Mengle-Gaw, L., and H . O. McDevitt. 1984. In Regulation of the Immune System. H .
Cantor, L. Chess, and E. Sercarz, editors. Alan R. Liss, New York. 29.
31 . Larhammar, D., U. Hammerling, M . Denaro, T. Lund, R. A. Flavell, L. Rask, and
P. A. Peterson. 1983. Structure of the murine immune response I-A/3 locus: sequence
of the I-A/3 gene and an adjacent a chain second domain exon. Cell. 34:179.
32 . Malissen, M., T. Hunkapiller, and L. Hood. 1983. Nucleotide sequence of a light chain
gene of the mouse I-A subregion: A/3`'. Science (Wash. DC). 221 :750.
33 . Estess, P., A. B. Begovich, M . Koo, P. P Jones, and H . O. McDevitt. 1986. Sequence
analysis and structure-function correlations ofmurine q, k, u, s, fhaplotype I-AO cDNA
clones. Proc. Natl. Acad. Sci. USA. 83:3594.
34. Choi, E., K. McIntyre, R. N. Germain, and J . G. Seidman. 1983. Murine I-A0 chain
polymorphism: nucleotide sequence of three allelic I-A(3 chain genes. Science (Wash. DC).
221:283.
35. Denaro, M., U. Hammerling, L. Rask, and P A. Peterson. 1984. The E'/3 gene may
have acted as the donor gene in a gene conversion-like event generating the Anm'20 mu-
tant. EMBO (Eur Mol. Bol. Organ.)J. 3 :2029.
36. Mengle-Gaw, L., and H. O. McDevitt. 1985. Predited protein sequence of the murine
I-Eas polypeptide chain from cDNA and genomic clones. Proc. Nad. Acad. Sci. USA.
82:2910.
37. Widera, G., and R. A. Flavell. 1984. The nucleotide sequence of the murine I-EOb im-
mune response gene: evidence for gene conversion events in class II genes of the major
histocompatibility complex. EMBO (Eur. Mol. Biol. Organ.) J 3 :1221.
38. Mengle-Gaw, L., and H . O. McDevitt. 1983. Isolation and characterization of a cDNA
clone for the murine I-EO polypeptide chain. Proc. Natl. Acad. Sci. USA. 80:7621.
39. Saito, H., R. A. Maki, L. K. Clayton, and S. Tonegawa. 1983 . Complete primary struc-984
￿
A UNIQUE SEQUENCE OF THE NZW I-ES CHAIN
tures of the E0 chain and gene of the mouse major histocompatibility complex. Proc.
Natl. Acad. Sci. USA. 80:5520.